JSC Grindeks

JSC Grindeks

JSC Grindeks is the leading pharmaceutical company in the Baltic States.

Its main fields of action are: research, development, manufacturing and sale of original products, generics and active pharmaceutical ingredients.

JSC Grindeks Group consists of four subsidiary companies in countries: Latvia, Estonia and Russia, as well as representative offices in 13 countries.

Kalendorius:

JSC Grindeks plans to publish its:

  • non-audited interim financial statement for the 12-month period of 2017 on 28 February 2018;
  • non-audited interim financial statement for the 3-month period of 2018 on 31 May 2018;
  • non-audited interim financial statement for the 6-month period of 2018 on 30 August 2018;
  • non-audited interim financial statement for the 9-month period of 2018 on 29 November 2018.

The audited separate and consolidated financial statement of Grindeks JSC of 2017 is scheduled for 27 April 2018.



 

Facebook Komentarai

%d bloggers like this: